CA3026041C - Compositions pharmaceutiques nasales a excipient poreux - Google Patents

Compositions pharmaceutiques nasales a excipient poreux

Info

Publication number
CA3026041C
CA3026041C CA3026041A CA3026041A CA3026041C CA 3026041 C CA3026041 C CA 3026041C CA 3026041 A CA3026041 A CA 3026041A CA 3026041 A CA3026041 A CA 3026041A CA 3026041 C CA3026041 C CA 3026041C
Authority
CA
Canada
Prior art keywords
active agent
composition
condition
testosterone
nasal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3026041A
Other languages
English (en)
Other versions
CA3026041A1 (fr
Inventor
Claudia Mattern
Original Assignee
M&P Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by M&P Pharma AG filed Critical M&P Pharma AG
Priority claimed from PCT/IB2017/053288 external-priority patent/WO2017208209A1/fr
Publication of CA3026041A1 publication Critical patent/CA3026041A1/fr
Application granted granted Critical
Publication of CA3026041C publication Critical patent/CA3026041C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

L'invention concerne des compositions pharmaceutiques nasales comprenant un excipient poreux et un agent actif, l'agent actif étant chargé sur une surface de l'excipient poreux située à l'intérieur des pores de l'excipient poreux, et la composition étant conçue pour être administrée par voie nasale. L'invention concerne également des procédés de fabrication et d'utilisation desdites compositions pharmaceutiques.
CA3026041A 2016-06-03 2017-06-02 Compositions pharmaceutiques nasales a excipient poreux Active CA3026041C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662345369P 2016-06-03 2016-06-03
US62/345,369 2016-06-03
PCT/IB2017/053288 WO2017208209A1 (fr) 2016-06-03 2017-06-02 Compositions pharmaceutiques nasales à excipient poreux

Publications (2)

Publication Number Publication Date
CA3026041A1 CA3026041A1 (fr) 2017-12-07
CA3026041C true CA3026041C (fr) 2026-04-21

Family

ID=

Similar Documents

Publication Publication Date Title
JP7571078B2 (ja) 多孔性賦形剤を含む経鼻用医薬組成物
JP6433490B2 (ja) シリカハイドロゲルコンポジット
JP2010513449A (ja) サブミクロン粒子に基づく治療活性物質の経粘膜送達のための医薬組成物
JP6040497B2 (ja) 無機粒子状物質の製造方法
Choudhari et al. Mesoporous silica drug delivery systems
CA3026041C (fr) Compositions pharmaceutiques nasales a excipient poreux
CN105030732A (zh) 壳聚糖包封液晶纳米粒所得微球及其制备方法
JP7158039B2 (ja) ゾル－ゲル／ヒドロゲル治療薬送達システム及びその方法
AU2018283777B2 (en) Amorphous nanostructured pharmaceutical materials
EA043077B1 (ru) Назальные фармацевтические композиции с пористым наполнителем
JP7796097B2 (ja) シリカハイドロゲルコンポジットおよびその使用
RU2261087C1 (ru) Способ введения малорастворимых в воде лекарственных веществ в эмульсионную основу
WO2013153210A1 (fr) Formulation à libération prolongée
JP2015523357A (ja) 目的物質の熱刺激放出のための多成分性の材料、調製プロセスおよび適用